SCS/SB 521 - Under this act, the Department of Corrections and all other state entities responsible for the care of persons detained or incarcerated in jails or prisons shall be required to ensure all such persons are assessed for substance abuse disorders; shall make available certain medication-assisted treatment services, consistent with a treatment plan developed by a physician; and shall not impose any arbitrary limitations on the type of medication or other treatment prescribed or dose or duration of the recommended services.

This act also modifies the list of covered medications to include formulations of buprenorphine other than tablets and formulations of naltrexone other than extended-release injectable formulations.

This act is substantially similar to SB 814 (2020) and a provision in SB 507 (2019).

SARAH HASKINS

Statutes affected:
Introduced (2497S.01): 191.1165

---

Senate Committee Minutes:
SENATE COMMITTEE MINUTES Bill No.: SB 521
Sponsor: Roberts
Hearing Date: 3/10/2021


COMMITTEE: Health and Pensions

CHAIRMAN: Onder

DATE REFERRED: 3/4/2021 DATE HEARING REQUESTED: 3/10/2021



STAFF:
Sarah Haskins
Katie O'Brien
Theckla Spainhower
Chris Sutherland


WITNESSES GIVING INFORMATION:



WITNESSES FOR:
Mark Parrino
Scott Breedlove - Myself
Arnie C. AC "Honest-Abe" DIENOFF - State Public Advocate-
Sean Grove - Mallinckrodt Pharmaceuticals
Paul Samuels - Please see attached testimony on behalf of the Legal Action Center
Cheryl Gardine - Center for Life Solutions Inc
Shantel Dooling - Missouri State Medical Association


WITNESSES AGAINST: